Results 181 to 190 of about 6,495,609 (392)
Rating neurologic impairment in multiple sclerosis
J. Kurtzke
semanticscholar +1 more source
We report the national burden of dermatopolymyositis mortality over the past quarter century using the US national vital statistics data. Age‐standardized mortality rates for dermatopolymyositis decreased at an annual rate of 3.8% each year, which was higher than the annual percent decrease for deaths from all other causes.
Elizabeth Matz, Ram R. Singh
wiley +1 more source
Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis [PDF]
Xueping Chen +6 more
openalex +1 more source
Polypharmacy and multiple sclerosis: A population-based study
Aníbal Chertcoff +4 more
openalex +1 more source
A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial Design [PDF]
E. Mark Haacke +16 more
openalex +1 more source
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah +5 more
wiley +1 more source
Safety of low-intensity repetitive transcranial magneTic brAin stimUlation foR people living with mUltiple Sclerosis (TAURUS): study protocol for a randomised controlled trial [PDF]
Kalina Makowiecki +10 more
openalex +1 more source
Objective In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently, and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of the trajectory of a ...
Ji Soo Kim +18 more
wiley +1 more source
Introduction There has been a surge in interest in identifying the factors that impact cognitive impairment (CI) in patients with multiple sclerosis (MS).
Nasim Rezaeimanesh +5 more
doaj +1 more source
Hemostasis biomarkers in multiple sclerosis [PDF]
Nicole Ziliotto +11 more
openalex +1 more source

